Clinical Trial Update: Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Guangxi evaluating regimens of albendazole, tribendimidine, and praziquantel for clonorchiasis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonorchiasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Praziquantel (Praziquantel)
• Tribendimidine (Tribendimidine)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Clonorchiasis | Phase 4 | Status: RECRUITING